| Biotechnology feed | All feeds
commercialization partner Covidien plc said the FDA had approved Exalgo, a once-daily, extended-release formulation of hydromorphone, for... BioWorld: Mar 3 2010 5:47AM Matching: palladone Find similar documents
commercialization partner Covidien plc said the FDA had approved Exalgo, a once-daily, extended-release formulation of hydromorphone, for moderate to severe pain in opioid... Therapeutics Daily: Mar 3 2010 2:28AM Matching: palladone Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.